TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
SRRK

Scholar Rock Holding Corp

Healthcare · Biotechnology

48.60$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow SRRK
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3,995.0% – – -308.0% -391.3% -673.8% -399.8% – – –
151.7% – – 6.4% 9.7% 14.0% 9.0% – – –
146.7% – – 38.9% 72.6% 123.0% 83.5% – – –
38.0% – – 38.9% 72.7% 123.2% 83.6% – – –
91.6% – – -103.3% 73.0% -151.1% -103.6% – – –
209.5% – – 15.2% 26.5% 27.9% 3.2% – – –
-5,361.2% – – -303.7% -412.2% 713.8% -517.3% – – –
– – – 240.4% 1,449.2% 106.2% 589.9% – – –
264.4% – – -1.8% 159.9% 132.8% -2.9% – – –
264.4% – – 238.5% 1,608.9% 238.9% 587.0% – – –
-9,091.8% – – -373.2% 805.4% 278.9% -330.1% – – –
-4,204.5% – – -323.2% -417.8% -701.7% -403.0% – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?